Compare PKE & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PKE | BME |
|---|---|---|
| Founded | 1954 | N/A |
| Country | United States | United States |
| Employees | 125 | N/A |
| Industry | Military/Government/Technical | Trusts Except Educational Religious and Charitable |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 680.4M | 593.0M |
| IPO Year | 1994 | 2005 |
| Metric | PKE | BME |
|---|---|---|
| Price | $31.28 | $45.81 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 189.3K | 39.1K |
| Earning Date | 05-15-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.53% | N/A |
| EPS Growth | ★ 93.10 | N/A |
| EPS | ★ 0.17 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $180.59 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $18.19 | $35.95 |
| 52 Week High | $39.86 | $46.43 |
| Indicator | PKE | BME |
|---|---|---|
| Relative Strength Index (RSI) | 31.20 | 65.10 |
| Support Level | $23.29 | $39.51 |
| Resistance Level | $35.94 | $46.43 |
| Average True Range (ATR) | 1.28 | 0.56 |
| MACD | -0.48 | -0.07 |
| Stochastic Oscillator | 0.79 | 77.85 |
Park Aerospace Corp is an aerospace company that develops and manufactures composite materials used to produce composite structures for the aerospace market. Its products include film adhesives, lightning strike protection materials, specialty ablative materials for rocket motors and nozzles, and materials for radome applications. The Company offers composite materials designed for hand lay-up and automated fiber placement (AFP) manufacturing applications, which are used in jet engines, large and regional transport aircraft, military aircraft, unmanned aerial vehicles (UAVs), business jets, general aviation aircraft, and rotary wing aircraft. It operates in North America, Asia, and Europe, with North America generating maximum revenue.
Blackrock Health Sciences Trust has an investment objective to provide total return and income mainly through long-term capital appreciation. The Trust invests the majority of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry.